BIOX.NASDAQBioceres Crop Solutions CORP
20-F: Bioceres Crop Solutions Corp. Files 20-F Annual Report
Sentiment:
Annual Results
Bioceres Crop Solutions Corp. files its annual report on Form 20-F, detailing its financial performance and operational activities for the fiscal year ended June 30, 2024.
Summary
- Bioceres Crop Solutions Corp. has filed its annual report on Form 20-F.
- The report includes audited consolidated financial statements prepared in accordance with IFRS.
- For the year ended June 30, 2024, total revenue was US$464.8 million, operating profit was US$44.8 million, and net income was US$6.2 million.
- The company's total indebtedness as of June 30, 2024, was US$259.7 million.
- The report details the company's business segments: Crop Protection, Seed and Integrated Products, and Crop Nutrition.
- The company faces risks related to its business strategy, intellectual property, operations in Latin America, and its ordinary shares.
Sentiment
Score: 6
Explanation: The document presents a mixed sentiment. While there's revenue growth and strategic partnerships, there are also significant risks and economic challenges.
Positives
- Revenue increased by 10.6% compared to the previous year.
- Operating profit remained strong.
- The company has a diverse product portfolio and a global presence.
- The company is focused on sustainable agricultural solutions.
- The company has a strong R&D engine to sustain long-term organic growth.
Negatives
- The company has a significant amount of debt.
- The company is exposed to risks related to operating in Latin America.
- The company is subject to intense competition in the crop productivity market.
- The company's business is highly seasonal and affected by factors beyond its control.
Risks
- Difficulties implementing inorganic growth strategy.
- Failure to realize benefits of future acquisitions.
- Difficulties in obtaining regulatory approvals.
- Dependence on the success of licensed HB4 technology.
- Global economic conditions and political instability.
- Fluctuations in currency exchange rates.
- Resistance to genetically modified crops.
- Cybersecurity threats.
- Changes in Argentine tax laws.
Future Outlook
The company expects to continue investing in R&D and expanding its international business.
Industry Context
The company operates in the agricultural biotechnology industry, which is characterized by intense competition and continuous technological development.
Comparison to Industry Standards
- The report mentions key competitors such as Bayer, BASF, Corteva, Syngenta AG, UPL Limited and FMC Corporation.
- The report highlights the company's leadership in the biological market for agriculture inputs.
- The report notes that the company's HB4 technology is the first drought-tolerant technology for soybean and wheat cropping systems.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Nasdaq Corporate Governance Exemptions | The company relies on home country practices in lieu of certain Nasdaq requirements related to board independence and committee composition. | Ongoing | May afford less protection to holders of ordinary shares. |
Legal Proceedings
- An injunction relating to a disputed transfer of shares that occurred in 1995 affects 29% of the shares we hold, and affects 44% of the total share capital of Rizobacter.
Related Party Transactions
- R&D Services Agreements between Bioceres Semillas and Rizobacter with INDEAR.
- Field Station Lease Agreement between INDEAR and Rizobacter.
- Storage Agreement between Synertech Industrias S.A. and Rizobacter.
- License Agreements between BCS Holding Inc and Trigall Genetics S.A.
- Service Agreements to Joint Ventures Trigall Genetics S.A., FD Admiral SAS, BCS Holding Inc. and INDEAR.
- Collaboration Agreement by and between Rizobacter and Espartina S.A.
- Note Purchase Agreement and HB4 Soy Supply Agreement with Moolec Science SA.
Stakeholder Impact
- Shareholders: Dilution from potential conversion of notes, fluctuation in share price.
- Employees: Potential impact from labor union disputes.
- Customers: Access to sustainable agricultural solutions.
- Suppliers: Potential impact from changes in economic conditions.
- Creditors: Ability to repay debt depends on future performance.
Next Steps
- Continue to lead development and commercialization of new agricultural biotechnology products.
- Scale-up production of Rizobacter and Pro Farm products.
- Commercialize HB4 seed products.
- Expand international business.
- Pursue strategic collaborations and acquisitions.
Key Dates
| Date | Description |
|---|---|
| 2001 | Bioceres S.A. was founded. |
| 2016-10-19 | Acquisition of a controlling stake in Rizobacter S.A. |
| 2017-11-14 | Bioceres Crop Solutions Corp is incorporated in the Cayman Islands |
| 2019-03-14 | Union Acquisition Corp. completed a business combination with Bioceres, becoming Bioceres Crop Solutions Corp. |
| 2020-05-06 | Board of directors approved a share repurchase program. |
| 2020-07-27 | Removal of all outstanding warrants from capital structure. |
| 2020-11-12 | Acquisition of remaining ownership interest in Verdeca LLC. |
| 2021-04-26 | Voluntary transfer of stock exchange listing to The Nasdaq Global Select Market. |
| 2022-07-12 | Closing of the Pro Farm Merger. |
| 2022-08-05 | Issuance of Secured Convertible Guaranteed Notes due 2026. |
| 2022-09-12 | Entry into a 10-year exclusive global distribution agreement with Syngenta. |
| 2023-07-18 | Entered into an exclusive agreement with Corteva Agriscience to advance the availability of biological solutions in Europe. |
| 2023-12-20 | Emergency Decree 70/2023 issued in Argentina. |
| 2024-06-10 | Acquired a controlling interest in Natal Agro S.R.L. |
| 2024-06-27 | Chamber of Deputies of the National Congress approved the final text of the Bases Law. |
| 2024-07-08 | Executive branch issued Decrees No. 592 and 593, whereby it enacted the Bases Law along with the Tax Package. |
| 2024-07-12 | Executive branch issued Decree No. 608 and 695, regulating certain rules of the Tax Package and the following four chapters of Title II of the Base Law. |
| 2024-08-05 | Executive branch issued Decree No. 608 and 695, regulating certain rules of the Tax Package and the following four chapters of Title II of the Base Law. |
| 2024-08-12 | Executive branch published Decree No. 713 in the Official Gazette through which it moved forward with the regulation of Section of the Bases Law related to contracts and transactional agreements (including concessions). |
| 2024-09 | Entered into a note purchase agreement and a HB4 soy supply agreement with Moolec Science SA. |
| 2024-10-24 | Annual general meeting held. |
Keywords
Bioceres, Crop Solutions, Annual Report, Financial Results, HB4 Technology, Agricultural Biotechnology, Latin America, Debt, Risk Factors, IFRS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.